Accenture, Royal Philips Electronics N.V. Test Brain-Controlled System For ALS Patients

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

(Reuters) - The Netherlands’ Royal Philips and IT consultancy Accenture are developing software to help people with neurodegenerative diseases like amyotrophic lateral sclerosis, commonly known as Lou Gehrig’s disease, live more independently.

The companies said they have built a trial application that lets patients with ALS, a disease that diminishes muscle action, issue “brain commands” to turn lights on and off or send an alert to a doctor.

The software works by connecting a wireless headset developed by Emotiv, a San Francisco-based startup, to a wearable device.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC